Max Planck Florida Researcher Receives Prestigious NIH New Innovator Award
Research into the neural mechanisms underlying addiction and eating disorders has earned Max Planck Florida Institute for Neuroscience researcher Dr. Sarah Stern an NIH Director’s New Innovator Award. This award will provide Dr. Stern and MPFI with $2.85 million in research funding support over five years, and is part of the NIH’s High-Risk-High Reward Research Program of the NIH Common Fund. - October 02, 2023
MPFI’s Wang Lab Awarded $1M Grant to Study Mechanism Behind Memory Decline in Alzheimer’s
Memory loss is one of the most devastating effects of Alzheimer's disease, yet the mechanisms behind it remain a mystery. MPFI is working to change that through a new $1,038,819 research award from the National Institute on Aging of the NIH. - August 23, 2023
MPFI Researcher Receives Prominent Award to Launch New Lab
The Max Planck Florida Institute for Neuroscience announces that Dr. Madineh Sarvestani has been named a Freeman Hrabowski Scholar by the Howard Hughes Medical Institute. The award provides up to $8.6 million for five to 10 years to support outstanding early-career faculty members who have strong potential to become leaders in the field and who are committed to advancing diversity, equity, and inclusion in science through their mentorship of trainees from populations underrepresented in science. - May 09, 2023
World-Renowned Research Leader Returns as COO of Max Planck Florida Institute for Neuroscience
Max Planck Florida Institute for Neuroscience is pleased to welcome neuroscientist and research infrastructure expert Dr. Ivan Baines back to South Florida as Chief Operating Officer at MPFI. Dr. Baines’ globe-spanning expertise includes work for the U.S. National Institutes of Health; 20 years as COO and Board Member for the Max Planck Institute of Molecular Biology and Genetics in Dresden, Germany, and as a former faculty member for Florida Atlantic University. - May 04, 2023